Doctors Note Logo

Published on: 1/27/2026

are ulcerative colitis patients immunocompromised

Sometimes, but not always. Ulcerative colitis itself does not automatically weaken the immune system, and people in remission who are not on immune suppressing medications are generally not considered immunocompromised. Risk increases mainly with treatments that suppress immunity, like corticosteroids, immunomodulators, biologics, or JAK inhibitors, and can also rise with severe flares or recent surgery, so there are several factors to consider; see below for important details that may affect vaccines, infection precautions, and the next steps you take with your clinician.

answer background

Explanation

Are People With Ulcerative Colitis Immunocompromised?

Short answer: Sometimes—but not always.
Whether someone with ulcerative colitis is considered immunocompromised depends largely on their treatment, disease activity, and overall health, rather than the diagnosis alone.

Below is a clear, balanced explanation based on well‑established medical guidance from major gastroenterology and public health organizations. The goal is to help you understand the risks without causing unnecessary worry, while still being honest about what matters most.


What Is Ulcerative Colitis?

Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the large intestine (colon and rectum). It is considered an autoimmune or immune‑mediated condition, meaning the immune system mistakenly attacks healthy tissue in the gut.

Common symptoms include:

  • Chronic diarrhea (sometimes with blood or mucus)
  • Abdominal pain or cramping
  • Urgency to have a bowel movement
  • Fatigue
  • Weight loss during active disease

Ulcerative colitis usually follows a pattern of flares (active disease) and remission (few or no symptoms).


Does Ulcerative Colitis Itself Weaken the Immune System?

Ulcerative colitis alone does not automatically make someone immunocompromised.

Here’s why:

  • The immune system in ulcerative colitis is overactive, not weak
  • The inflammation is largely localized to the colon
  • Many people with mild disease and no immune‑suppressing medications have normal immune defenses

So, if someone has ulcerative colitis and is:

  • In remission
  • Not taking immune‑suppressing medications
  • Otherwise healthy

They are generally not considered immunocompromised.


When Ulcerative Colitis Can Lead to Immunocompromise

People with ulcerative colitis may be considered immunocompromised under certain circumstances—primarily related to treatment, not the disease itself.

1. Medications That Suppress the Immune System

Many effective treatments for ulcerative colitis work by calming an overactive immune response. While this helps control inflammation, it can also reduce the body’s ability to fight infections.

Medications associated with immune suppression include:

  • Corticosteroids

    • Examples: prednisone, methylprednisolone
    • Higher doses or long‑term use increase infection risk
  • Immunomodulators

    • Examples: azathioprine, 6‑mercaptopurine
    • Affect white blood cell function
  • Biologic therapies

    • Examples: anti‑TNF drugs, integrin inhibitors, IL‑12/23 inhibitors
    • Target specific immune pathways
  • JAK inhibitors

    • Oral medications that alter immune signaling

People taking these medications are often medically classified as immunocompromised, especially if using combinations or higher doses.


2. Severe or Poorly Controlled Disease

Severe ulcerative colitis can weaken the body indirectly by:

  • Causing chronic inflammation
  • Leading to nutritional deficiencies
  • Increasing physical stress and fatigue

While this does not equal classic immune suppression, it can make it harder to recover from illness.


3. Recent Surgery or Hospitalization

Those who have had:

  • Recent bowel surgery
  • Hospital treatment for severe flares
  • IV steroids or biologics

May have temporary immune vulnerability, particularly in the weeks following treatment.


What Does “Immunocompromised” Mean in Daily Life?

Being immunocompromised does not mean constant illness or living in fear. It means being more mindful of certain risks.

Potential effects may include:

  • Higher risk of some infections
  • More severe illness when infections occur
  • Need for careful vaccine planning
  • Closer monitoring by healthcare providers

Many people with ulcerative colitis on immune‑modifying therapy live full, active lives with proper medical care.


Vaccines and Ulcerative Colitis

Vaccination is an important topic for people with ulcerative colitis, especially those on immune‑suppressing medications.

General principles include:

  • Inactivated vaccines are usually safe and recommended
  • Live vaccines may not be safe for people who are immunocompromised
  • Timing matters—some vaccines work best before starting immune‑suppressing therapy

This is an area where individualized medical advice is essential.


Are Ulcerative Colitis Patients at Higher Risk for Serious Infections?

The risk depends on three key factors:

  1. Medication type and dose
  2. Disease activity
  3. Other health conditions (age, diabetes, lung disease, etc.)

To put it in perspective:

  • A person with ulcerative colitis in remission and no immune‑suppressing drugs may have no meaningful increased risk
  • Someone on high‑dose steroids or combination therapy may have a moderately increased risk, which is usually manageable with monitoring

Doctors carefully balance benefit vs. risk when choosing treatments.


How to Protect Your Health Without Overdoing It

If you have ulcerative colitis, especially if you are on immune‑modifying treatment, practical steps can help reduce risk without limiting your life.

Helpful habits include:

  • Washing hands regularly
  • Staying up to date with recommended vaccines
  • Avoiding close contact with people who are clearly sick
  • Eating a balanced diet to support immune function
  • Reporting fevers, persistent cough, or unusual symptoms early

These are reasonable precautions, not extreme measures.


When Should You Be More Concerned?

You should speak to a doctor promptly if you have ulcerative colitis and experience:

  • High or persistent fever
  • Shortness of breath
  • Severe abdominal pain
  • Black or bloody stools beyond your usual pattern
  • Signs of serious infection

These situations can be life‑threatening if ignored, and early care makes a real difference.


Understanding Your Symptoms Matters

Symptoms of ulcerative colitis can overlap with other digestive conditions, infections, or medication side effects. If you’re unsure what your symptoms might mean, you may consider doing a free, online symptom check for Ulcerative Colitis to better understand what could be going on before speaking with a healthcare professional.

This can be a helpful starting point—but it should never replace medical care.


The Bottom Line

Ulcerative colitis does not automatically mean you are immunocompromised.

  • The condition itself involves immune overactivity, not weakness
  • Certain treatments can suppress the immune system
  • Risk varies widely from person to person
  • Most people manage ulcerative colitis safely with proper care

The most important step is to have open conversations with your doctor about your medications, infection risk, vaccines, and any new or concerning symptoms. Personalized medical advice is essential—especially when symptoms are severe or potentially life‑threatening.

With the right information and support, people with ulcerative colitis can make informed choices and protect their health without unnecessary fear.

(References)

  • * Lichtenstein GR, Loftus EV Jr, Isaacs KL, Regueiro RC, Gerson LB, Sands BE. Immunosuppression and infection risk in inflammatory bowel disease: a review of the evidence. J Crohns Colitis. 2018 Sep 28;12(10):1135-1147. doi: 10.1093/ecco-jcc/jjy088. PMID: 30282470.

  • * Sands BE. Risk of Infection in Patients With Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2020 Sep;49(3):529-541. doi: 10.1016/j.gtc.2020.04.004. PMID: 32977823.

  • * Cohen R, Quigley EMM, Cheifetz AS, Abreu MT. Immunogenicity and Infection Risk with Biologic Therapies for Inflammatory Bowel Disease: A Comprehensive Review. Dig Dis Sci. 2020 Jan;65(1):15-32. doi: 10.1007/s10620-019-05973-1. Epub 2019 Dec 9. PMID: 31821812.

  • * Shah SC, Khera A, Cheifetz AS. Management of Immunosuppression in Patients with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2022 Dec;51(4):721-744. doi: 10.1016/j.gtc.2022.08.001. PMID: 36306535.

  • * Vande Casteele N, Mody RR, Zylberberg A, et al. Risk of serious infection in patients with inflammatory bowel disease treated with thiopurines, methotrexate, or tofacitinib: a systematic review and meta-analysis. Aliment Pharmacol Ther. 2022 Dec;56(11-12):1615-1632. doi: 10.1111/apt.17240. PMID: 36316278.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Ulcerative Colitis

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.